| Date | Description | Quality | Ticker | Source |
|---|---|---|---|---|
| 20 Nov 2026 | #173: How does Mixue sell $1 tea across 60,000 stores? | medium | NONE | Substack |
|
NONE·
medium·
Substack
·
#173: How does Mixue sell $1 tea across 60,000 stores?
India lacks a Mixue-style player: the wide-open prize is a sub-Rs30 branded beverage chain built on an owned farm-to-cup supply chain and small-town 'Bharat' density, not asset-light aggregation competing on discounts. |
||||
| 20 Nov 2026 | Are Global Markets Entering a New Phase? Political Uncertainty, AI Investments and the Changing Flow of Money | medium | NONE | Other |
|
NONE·
medium·
Other
·
Are Global Markets Entering a New Phase? Political Uncertainty, AI Investments and the Changing Flow of Money
Foreign investors are rotating out of expensive AI hardware plays into India, which offers domestic earnings exposure across banking, consumption and manufacturing at more reasonable valuations after prolonged selling. |
||||
| 20 Nov 2026 | Is GTA VI the last hope of a struggling industry? | high | NONE | Substack |
|
NONE·
high·
Substack
·
Is GTA VI the last hope of a struggling industry?
The blockbuster AAA model is breaking: costs above $1 billion and decade-long timelines collide with players spending 14% less and 54% of their time on old live-service titles, so GTA VI is a singular outlier rather than an industry saviour. |
||||
| 20 Nov 2026 | #172: How did China’s Leaderdrive crash the price of robot gears? | medium | NONE | Substack |
|
NONE·
medium·
Substack
·
#172: How did China’s Leaderdrive crash the price of robot gears?
India has robotics ambition but no domestic capacity in harmonic reducers, roller screws or precision bearings, so cheap Chinese imports raise near-term robot affordability while foreclosing the window to build local capability. |
||||
| 19 Nov 2026 | #171: Why did India put 147% duty on Chinese lasers? | low | SLTL | Substack |
|
SLTL·
low·
Substack
·
#171: Why did India put 147% duty on Chinese lasers?
India's anti-dumping duty of up to 147.2% on Chinese laser machines shields domestic laser-machine builders like Sahajanand from a price flood that was killing them, buying protected time to scale. |
||||
| 19 Nov 2026 | #171: Why did India put 147% duty on Chinese lasers? | medium | NONE | Substack |
|
NONE·
medium·
Substack
·
#171: Why did India put 147% duty on Chinese lasers?
Cheap Chinese lasers make Indian fabricators more competitive but create dependence; the duty buys time, and the payoff depends on building fibre, diode and combiner component capability rather than assembling Chinese parts. |
||||
| 19 Nov 2026 | Who pays to invent the energy future? | high | NONE | Substack |
|
NONE·
high·
Substack
·
Who pays to invent the energy future?
Public energy R&D is scare-driven and fades, while durable innovation comes from scaled equipment makers, mostly Chinese; India underspends on R&D and renewable research despite shocks. |
||||
| 19 Nov 2026 | Who pays to invent the energy future? | medium | OLAELEC | Substack |
|
OLAELEC·
medium·
Substack
·
Who pays to invent the energy future?
Ola Electric’s pivot to dealerships offloads inventory, GST and service burdens to local dealers, aiming to stem ₹362 crore quarterly losses and rebuild market share after delivery collapse. |
||||
| 19 Nov 2026 | #170: Why can China build a drug factory in 100 days? | medium | NONE | Substack |
|
NONE·
medium·
Substack
·
#170: Why can China build a drug factory in 100 days?
Cheap Chinese bioreactors and resin slash the entry cost for Indian biosimilar plants overnight, but the same discount risks swapping dependence on three Western suppliers for dependence on a few Chinese ones in a strategic sector. |
||||
| 19 Nov 2026 | #170: Why can China build a drug factory in 100 days? | high | MORIMATSU | Substack |
|
MORIMATSU·
high·
Substack
·
#170: Why can China build a drug factory in 100 days?
Morimatsu sells factories as modular products, cutting plant capex 20-50% and build time by years; Pharmadule and Bioengineering acquisitions plus integrated software create facility-level lock-in, and its order book is surging even as it holds prices down. |
||||
| 19 Nov 2026 | #170: Why can China build a drug factory in 100 days? | high | DUONING | Substack |
|
DUONING·
high·
Substack
·
#170: Why can China build a drug factory in 100 days?
Duoning is vertically integrating the entire single-use bioprocessing stack — pumps, bags, resin, filtration — so it can undercut Western oligopolists by 40-50% while capturing every layer's margin, just as Chinese drugmakers are forced to qualify domestic suppliers. |
||||
| 18 Nov 2026 | #169: Why does BYD now earn 53% of revenue abroad? | low | NONE | Substack |
|
NONE·
low·
Substack
·
#169: Why does BYD now earn 53% of revenue abroad?
As global carmakers seek to avoid total dependence on China, India's ancillary firms — Sona Comstar, Samvardhana Motherson, Bharat Forge, Uno Minda, Endurance — are winning EV driveline, motor and lightweighting business, offsetting India's deeper vulnerability in cells and magnets. |
||||
| 18 Nov 2026 | Portfolio Update — November 2026: I’ve Exited E2E. Capital Preservation Comes First. | low | E2E | Substack |
|
E2E·
low·
Substack
·
Portfolio Update — November 2026: I’ve Exited E2E. Capital Preservation Comes First.
Exited the position because the company is investing heavily today and the return on that investment a few years out cannot be confidently assessed; capital preservation takes priority over uncertain payoff. |
||||
| 18 Nov 2026 | Can AI talk the way India does? | high | BAJFINANCE | Substack |
|
BAJFINANCE·
high·
Substack
·
Can AI talk the way India does?
Voice AI is a real business lever: bots cost about a third of humans, conversion doubled to 17%, and proprietary call recordings drive sizable loan disbursals. |
||||
| 18 Nov 2026 | Can AI talk the way India does? | medium | NONE | Substack |
|
NONE·
medium·
Substack
·
Can AI talk the way India does?
Morbi gas and freight disruptions shut unorganized tile capacity, letting branded makers with contracted fuel expand volumes and triple profits as the price gap narrows. |
||||
| 18 Nov 2026 | Can AI talk the way India does? | medium | AXISBANK | Substack |
|
AXISBANK·
medium·
Substack
·
Can AI talk the way India does?
Owning customer call recordings gives Axis leverage in voice AI; its AXIOM bots handle most collection and sales calls, though financial impact isn't disclosed. |
||||
| 18 Nov 2026 | #168: How does China print 6.7bn DNA letters in two days? | high | GENSCRIPT | Substack |
|
GENSCRIPT·
high·
Substack
·
#168: How does China print 6.7bn DNA letters in two days?
GenScript has turned DNA synthesis into a fab-like, low-cost industrial process via its GenTitan chip, then monetises it through a Gene-to-Protein funnel up to CDMO and Legend's CARVYKTI. It is becoming the physical wet-lab layer that AI drug discovery must rent. |
||||
| 18 Nov 2026 | #168: How does China print 6.7bn DNA letters in two days? | medium | NONE | Substack |
|
NONE·
medium·
Substack
·
#168: How does China print 6.7bn DNA letters in two days?
India depends on China for genes, plasmids and vectors just as it does for APIs, and is missing the China-plus-one opening in biologics CDMO and gene synthesis because BioE3 remains a press release while Singapore captures the capacity. |
||||
| 17 Nov 2026 | FirstCry Q2 FY27 at ₹179: The Customers Are Back. Where Is the Cash? | low | FIRSTCRY | Substack |
|
FIRSTCRY·
low·
Substack
·
FirstCry Q2 FY27 at ₹179: The Customers Are Back. Where Is the Cash?
Quick commerce has undermined FirstCry's core advantage: parents can get the same branded baby products delivered faster elsewhere, so the store-plus-own-label model may struggle to sustain growth and cash generation. |
||||
| 17 Nov 2026 | #167: Why does Temu have 416mn users, none in India? | medium | NONE | Substack |
|
NONE·
medium·
Substack
·
#167: Why does Temu have 416mn users, none in India?
Blocking Temu was a defensible consumer-facing win for India, but it did nothing about the record ~$112bn China trade deficit; Chinese factory goods still reach Indian buyers upstream, through wholesale, quick-commerce and importers. |
||||
| 17 Nov 2026 | #167: Why does Temu have 416mn users, none in India? | medium | MEESHO | Substack |
|
MEESHO·
medium·
Substack
·
#167: Why does Temu have 416mn users, none in India?
India's regulatory wall kept Temu out while Meesho grew into the same factory-direct, low-price, small-town demand gap, making it the listed Indian owner of that model — though holding margins against Amazon and Flipkart is the open question. |
||||
| 17 Nov 2026 | Chandan Healthcare - high growth low valuation diagnostic company | high | CHANDAN | Other |
|
CHANDAN·
high·
Other
·
Chandan Healthcare - high growth low valuation diagnostic company
Franchise-led hub-and-spoke expansion (to 3,000+ franchisees) should rapidly lift utilisation of owned labs and, given >50% franchise EBITDA margins, sharply raise PAT growth without further equity dilution. |
||||
| 17 Nov 2026 | The Small Cap Behind India's Pharma Supply Chain Is Entering a New Growth Phase | high | AKUMS | Substack |
|
AKUMS·
high·
Substack
·
The Small Cap Behind India's Pharma Supply Chain Is Entering a New Growth Phase
Akums is India’s largest pharma contract manufacturer whose built-out capacity was de-rated as order-starved and pricing-powerless. With orders recovering—revenue +23%, operating profit +65%, profit doubled—and founders/PE holding, the business looks misunderstood. |
||||
| 17 Nov 2026 | ICRA at ₹4,499: A ratings moat, a software bet. What is priced in? | high | ICRA | Substack |
|
ICRA·
high·
Substack
·
ICRA at ₹4,499: A ratings moat, a software bet. What is priced in?
ICRA has a durable ratings franchise with recurring fees and operating leverage, but the current price already requires respectable growth; its analytics/software expansion is an uncertain cash-consuming bet. |
||||
| 17 Nov 2026 | Indian hotels name their price, and it’s steep | high | NONE | Substack |
|
NONE·
high·
Substack
·
Indian hotels name their price, and it’s steep
Premium branded Indian hotels have structural pricing power from scarce supply, MICE/weddings and dynamic corporate pricing; asset-light management contracts support high-margin growth. |
||||
| 17 Nov 2026 | #166: Why did India import ~54,000t of magnets from China? | high | NONE | Substack |
|
NONE·
high·
Substack
·
#166: Why did India import ~54,000t of magnets from China?
India's ₹7.3k crore magnet scheme targets only 6,000t versus ~54,000t of annual imports, and factories will remain shells without Chinese-controlled dysprosium/terbium and separation know-how, so the import dependence thesis stays intact. |
||||
| 16 Nov 2026 | Vedanta Oil & Gas (VOGL) - Can It Reclaim Its Old Glory? | medium | VOGL | Other |
|
VOGL·
medium·
Other
·
Vedanta Oil & Gas (VOGL) - Can It Reclaim Its Old Glory?
VOGL’s large 2C resources and Rajasthan infrastructure could arrest production decline and extend runway if 2C-to-2P conversion accelerates, but short ~5-year 2P reserve life and output decline remain overhangs. |
||||
| 16 Nov 2026 | #165: How did Xiaomi build 800,000 cars in 30 months? | medium | NONE | Substack |
|
NONE·
medium·
Substack
·
#165: How did Xiaomi build 800,000 cars in 30 months?
India captured only handset assembly, not the operating system, services, chip design and ecosystem where profit sits; without that high-margin layer, Indian electronics firms cannot copy a low-margin hardware model and move up the value chain. |
||||
| 16 Nov 2026 | Altius Q2 FY27 at ₹174: The 9% Yield Is There. Is the Growth? | low | ALTIUS TELECOM INFRASTRUCTURE | Substack |
|
ALTIUS TELECOM INFRASTRUCTURE·
low·
Substack
·
Altius Q2 FY27 at ₹174: The 9% Yield Is There. Is the Growth?
Own telecom infrastructure assets to collect a ~9% cash distribution, with modest growth as the upside; Q2 FY27 showed cash EBITDA up 5.7%, raising doubts on the growth leg. |
||||
| 16 Nov 2026 | Coal India’s largest subsidiary goes public | medium | NONE | Substack |
|
NONE·
medium·
Substack
·
Coal India’s largest subsidiary goes public
Pharma sales are growing 12% but margins are being crushed by acquisition funding, US launch spend, generic price wars and government margin caps — paying a steep upfront cost for future pipelines. |
||||
| 16 Nov 2026 | Coal India’s largest subsidiary goes public | high | MCL | Substack |
|
MCL·
high·
Substack
·
Coal India’s largest subsidiary goes public
Lowest-cost, high-volume Coal India subsidiary with 80% dividend payout offers minority investors a cash-generative coal asset, but gains are capped by parent-set prices and clouded by a ₹31,000 crore retrospective Odisha tax claim. |
||||
| 16 Nov 2026 | #164: Why does Ming Fai yield nearly 10%? | high | KIMIRICA | Substack |
|
KIMIRICA·
high·
Substack
·
#164: Why does Ming Fai yield nearly 10%?
Local manufacturing let Kimirica capture close to 70% of India's hotel amenities market from importers like Ming Fai, with ~Rs300cr revenue, marquee global clients, Carnelian backing and a Rs1,000cr revenue ambition, though exports face tariff walls and thin margins. |
||||
| 16 Nov 2026 | #164: Why does Ming Fai yield nearly 10%? | high | MINGFAI | Substack |
|
MINGFAI·
high·
Substack
·
#164: Why does Ming Fai yield nearly 10%?
Trades at ~5x earnings, 0.64x NCAV and 0.4x tangible book with net cash of ~$43mn against a ~$68mn market cap and a near-10% yield, but collapsing gross margins (25.1% to 19.1%) from the Cambodia shift make it a value-trap question. |
||||
| 15 Nov 2026 | Aerospace Megatrend | medium | NONE | Substack |
|
NONE·
medium·
Substack
·
Aerospace Megatrend
Aircraft demand far outstrips supply, with a 10-11 year OEM order backlog and global supply chains shifting toward low-cost geographies. India's labour, power and skill advantages plus a tripling domestic fleet position it to capture this multi-year aerospace opportunity. |
||||
| 14 Nov 2026 | #163: Why did Raytron’s profit jump 259%? | high | RAYTRONTECHNOLOGY | Substack |
|
RAYTRONTECHNOLOGY·
high·
Substack
·
#163: Why did Raytron’s profit jump 259%?
Raytron's relentless pixel shrink and wafer-level packaging let it sell thermal cores far cheaper than Western incumbents, driving 259% profit growth and positioning it as the default supplier for drones, cars and physical-AI sensing. |
||||
| 14 Nov 2026 | #163: Why did Raytron’s profit jump 259%? | medium | NONE | Substack |
|
NONE·
medium·
Substack
·
#163: Why did Raytron’s profit jump 259%?
India still imports ~half its drone components, including thermal cores two generations behind Raytron's, so strategic necessity plus a Chinese-parts ban creates a domestic opportunity for MKU, BEL and new microbolometer capacity. |
||||
| 14 Nov 2026 | Shiprocket Ltd: Your All-in-One eCommerce Growth Partner | medium | SHIPROCKET | Other |
|
SHIPROCKET·
medium·
Other
·
Shiprocket Ltd: Your All-in-One eCommerce Growth Partner
Investor sees Shiprocket as an interesting bet: a platform enabling small merchants, founded by learn-from-failure entrepreneurs, with core business profitable and emerging-business losses narrowing toward overall profitability. |
||||
| 14 Nov 2026 | ShipRocket: Your All-in-One eCommerce Growth Partner | medium | SHIPROCKET | Other |
|
SHIPROCKET·
medium·
Other
·
ShipRocket: Your All-in-One eCommerce Growth Partner
Post-IPO Shiprocket is close to break-even: the core shipping business is already profitable and emerging-segment EBITDA losses have shrunk sharply, so profitability looks near. Founders' prior failures are seen as valuable learning. |
||||
| 14 Nov 2026 | #162: Why do Chinese brands now sweep 70% of robot vacuums? | high | NONE | Substack |
|
NONE·
high·
Substack
·
#162: Why do Chinese brands now sweep 70% of robot vacuums?
Chinese robot-vacuum brands dominate through six-month iteration, LiDAR/AI hardware, and patent walls, using vacuums as a low-cost training ground for embodied AI; the same ecosystem also kills laggards lacking proprietary moats. |
||||
| 13 Nov 2026 | #161: Why did a $3,000 laser part crash to $150? | low | NONE | Substack |
|
NONE·
low·
Substack
·
#161: Why did a $3,000 laser part crash to $150?
India's laser-marking trade is assembly-strong but component-thin: every galvo, laser source and control card is imported from China. Domestic manufacture of these precision parts is the gap a serious component push, or PLI-style scheme, should target. |
||||
| 13 Nov 2026 | India’s food inflation story gets worrisome | high | NONE | Substack |
|
NONE·
high·
Substack
·
India’s food inflation story gets worrisome
Food inflation is likely to stay elevated as a lopsided monsoon, El Niño, and fertilizer/energy costs squeeze staples; this limits RBI rate cuts until grocery prices cool. |
||||
| 13 Nov 2026 | #160: Why does China recover 90% of the lithium India ignores? | high | SUNRESIN | Substack |
|
SUNRESIN·
high·
Substack
·
#160: Why does China recover 90% of the lithium India ignores?
Sells integrated separation systems, not just resin beads, giving it a low-cost moat across lithium DLE, peptide carrier resins and gallium recovery — with 51% gross margins and locked-in turnkey customers as Chinese tech controls tighten. |
||||
| 13 Nov 2026 | #160: Why does China recover 90% of the lithium India ignores? | medium | NONE | Substack |
|
NONE·
medium·
Substack
·
#160: Why does China recover 90% of the lithium India ignores?
India has strength at both ends — lithium resources and generics manufacturing — but is thin in the middle separation layer, so value flows to China; building domestic resin/sorbent capability is a smaller, winnable industrial opportunity. |
||||
| 12 Nov 2026 | #159: Why does $800 of Chinese audio gear beat a $3,499 rival? | medium | NONE | Substack |
|
NONE·
medium·
Substack
·
#159: Why does $800 of Chinese audio gear beat a $3,499 rival?
India has the brands and buyers but no silicon, analogue-design depth or measurement culture; local 'assembly' is imported kits, so the value accrues to Chinese suppliers like Topping and SMSL unless component incentives produce real design capability. |
||||
| 12 Nov 2026 | #159: Why does $800 of Chinese audio gear beat a $3,499 rival? | high | BOAT | Substack |
|
BOAT·
high·
Substack
·
#159: Why does $800 of Chinese audio gear beat a $3,499 rival?
India's dominant TWS brand with a proven D2C model, ~₹3.1k cr FY25 revenue and a return to profit, but its own filing admits heavy China/Vietnam sourcing — a brand without a supply chain, which is the key risk into its ₹1.5k cr IPO. |
||||
| 12 Nov 2026 | Artemis Medicare Services Ltd | high | ARTEMISMED | Other |
|
ARTEMISMED·
high·
Other
·
Artemis Medicare Services Ltd
Artemis is building a high-acuity hospital network around its Gurugram flagship, using medical value travel, asset-light formats and management contracts to lift ARPOB, occupancy and operating leverage, driving margin expansion. |
||||
| 12 Nov 2026 | The Ice Houses of the Grid: India's Battery Storage Boom, and Who Actually Keeps the Money | Sector Deep Dive | high | NONE | Substack |
|
NONE·
high·
Substack
·
The Ice Houses of the Grid: India's Battery Storage Boom, and Who Actually Keeps the Money | Sector Deep Dive
Argues BESS profits sit with early project owners earning scarcity rents and grid-equipment suppliers, plus specialty chemical firms selling non-China battery materials; cell making and container assembly are where India spends most and earns least. |
||||
| 12 Nov 2026 | The world sees a boom in Chinese yuan bonds | medium | NONE | Substack |
|
NONE·
medium·
Substack
·
The world sees a boom in Chinese yuan bonds
Indian airlines retain pricing freedom and a slot-constrained duopoly, but high jet fuel and dollar costs threaten sector-wide losses despite low average fares. |
||||
| 12 Nov 2026 | #158: Why did one Chinese firm cut X-ray detector prices 60%? | medium | NONE | Substack |
|
NONE·
medium·
Substack
·
#158: Why did one Chinese firm cut X-ray detector prices 60%?
India imports ~70% of medical devices and has almost no domestic detector manufacturing, so it gains affordability but imports the chokepoint — a trap now repeating in battery gigafactory inspection. |
||||
| 12 Nov 2026 | #158: Why did one Chinese firm cut X-ray detector prices 60%? | high | IRAYTECHNOLOGY | Substack |
|
IRAYTECHNOLOGY·
high·
Substack
·
#158: Why did one Chinese firm cut X-ray detector prices 60%?
It built X-ray detectors on China's subsidised display-panel supply and self-designed crystal-growing machines, cutting industry prices 40-60% while holding >50% gross margins, winning ~20% global detector share and over half of EV battery inspection. |
||||